Our aim was to investigate the effect of switching TDF to TAF on liver enzymes and renal and lipid profile Consecutive HIV patients enrolled in Surveillance Cohort Long-term Toxicity Antiretrovirals/Antivirals (SCOLTA) project switching from TDF to TAF for any reasons were included. Changes from baseline (T0) to 6-month followup (T1) were evaluated using paired t-test if differences were normally distributed and using signed rank test if not
Switching from Tenofovir disoproxil fumarate (TDF) to Tenofovir alafenamide (TAF) lowers alanine transaminase (ALT) and aspartate transaminase (AST) in patients with infection with or without viral hepatitis co-infection
G. F. Pellicanò;
2019-01-01
Abstract
Our aim was to investigate the effect of switching TDF to TAF on liver enzymes and renal and lipid profile Consecutive HIV patients enrolled in Surveillance Cohort Long-term Toxicity Antiretrovirals/Antivirals (SCOLTA) project switching from TDF to TAF for any reasons were included. Changes from baseline (T0) to 6-month followup (T1) were evaluated using paired t-test if differences were normally distributed and using signed rank test if notFile in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
